2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow ARRY-403: new trials by email Literature Review of ARRY-403 trials Research Report on ARRY-403
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of ARRY-403 in Patients With Type 2 Diabetes ARRY-403, glucokinase activator; oral, Placebo; oral - Type 2 Diabetes | Phase 1 | Completed | Array Biopharma, now a wholly owned subsidiary of Pfizer | 128 | 2009-08-01 | 2020-10-06 |
| A Safety Study of ARRY-403 in Patients With Type 2 Diabetes ARRY-403, glucokinase activator; oral, Placebo; oral - Type 2 Diabetes | Phase 1 | Completed | Array BioPharma | 41 | 2009-03-01 | 2012-08-30 |
Array BioPharma (1) · Array Biopharma, now a wholly owned subsidiary of Pfizer (1)
United States (2)